GeneDx Holdings Corp
NASDAQ:WGS
GeneDx Holdings Corp
NASDAQ:WGS
Price:
19.96 USD
-2.11%
Market Closed
Updated:
Jun 1, 2024
EV/GP
Enterprise Value to Gross Profit
Enterprise Value to Gross Profit
4.1
Current
-1.8
Median
5.1
Industry
Higher
than median
Lower
than industry value
All Countries
| Market Cap | EV/GP | ||||
|---|---|---|---|---|---|
| US |
|
GeneDx Holdings Corp
NASDAQ:WGS
|
521.4m USD | 4.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
96.9B USD | 4.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
87.3B EUR | 4.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
74.6B USD | 2.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.5B EUR | 4.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.3B USD | 5.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.6B USD | 6.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.9B USD | 5.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 4.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.4B EUR | 4.2 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 128.5 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/GP
N/A
2-Years Forward
EV/GP
N/A
3-Years Forward
EV/GP
N/A
You don't have any saved screeners yet
